Source: Annual Congress 2003 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Eneser, C. J. Emery, G. Barer, W. Wallace, T. Higgenbottam, D. Kiely, I. Armstrong (Sheffield, United Kingdom). Assessing pulmonary vascular disease: is cardiac catheterisation a sufficiently robust gold standard?. Eur Respir J 2003; 22: Suppl. 45, 3663

Member's Comments

No comment yet.

Related content which might interest you: Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? Source: Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019 Year: 2020 Non-invasive versus invasive heamodynamic evaluation in an heterogeneous pulmonary hypertension population: When echo goes in the cath-lab Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Right heart catheterisation: best practice and pitfalls in pulmonary hypertension Source: Eur Respir Rev 2015; 24: 642-652 Year: 2015 Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension Source: Eur Respir J, 52 (1) 1800738; 10.1183/13993003.00738-2018 Year: 2018 Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction Source: Eur Respir J 2012; 39: 919-926 Year: 2012 Acute pulmonary embolism: which standard treatment and for how long? Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art Source: Eur Respir Rev 2009; 19: 55-58 Year: 2010 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 Pulmonary embolism and pulmonary hypertension - is our follow up adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Fluid challenge test during heart catheterization in normal subjects and in a heterogeneous population with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Late Breaking Abstract - An evaluation of standard UK pulmonary rehabilitation post pulmonary embolism Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018 Early recognition of pulmonary arterial hypertension in risk patients using exercise stress echocardiography and right heart catheterisation Source: Eur Respir J 2007; 30: Suppl. 51, 287s Year: 2007 BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020 Year: 2020 Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 422-430 Year: 2015 Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 939-944 Year: 2012